We are live on ! Find out more
RGNX icon

Regenxbio

166 hedge funds and large institutions have $399M invested in Regenxbio in 2025 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 63 increasing their positions, 51 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

53% more first-time investments, than exits

New positions opened: 23 | Existing positions closed: 15

24% more repeat investments, than reductions

Existing positions increased: 63 | Existing positions reduced: 51

16% more capital invested

Capital invested by funds: $345M → $399M (+$54.3M)

4% more funds holding

Funds holding: 159166 (+7)

7% less call options, than puts

Call options by funds: $1.52M | Put options by funds: $1.64M

1.49% less ownership

Funds ownership: 83.37%81.88% (-1.5%)

Holders
166
Holders Change
+7
Holders Change %
+4.4%
% of All Funds
2.18%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
23
Increased
63
Reduced
51
Closed
15
Calls
$1.52M
Puts
$1.64M
Net Calls
-$120K
Net Calls Change
-$321K
Name Holding Trade Value Shares
Change
Change in
Stake
CWMK
176
Caliber Wealth Management (Kansas)
Kansas
-$132K -16,095 Closed
HT
177
Headlands Technologies
Illinois
-$108K -13,139 Closed
VOYA Investment Management
178
VOYA Investment Management
Georgia
-$107K -12,998 Closed
ProShare Advisors
179
ProShare Advisors
Maryland
-$94.2K -11,468 Closed
Prudential Financial
180
Prudential Financial
New Jersey
-$87.3K -10,631 Closed
TRSOTSOK
181
Teachers Retirement System of the State of Kentucky
Kentucky
-$11K -1,339 Closed

RGNX Hedge Fund Activity: Q3 2025 in Review

166 of the 7,619 institutional investors tracked by Wall St. Rank reported a position in Regenxbio (RGNX) for Q3 2025, worth a combined $399M — up 16% from $345M a quarter earlier.

Buyers outnumbered sellers: 23 funds opened new RGNX positions and 15 closed out — a net gain of 8 holders — while 63 added to existing stakes and 51 trimmed.

The largest buyer was Morgan Stanley, adding an estimated $6.27M. The largest seller was Balyasny Asset Management, exiting entirely with an estimated $6.54M sold.

  • 166 institutional investors held Regenxbio (RGNX) as of Q3 2025, up from 159 in Q2 2025.
  • Funds reported $399M of Regenxbio stock for Q3 2025, up 16% quarter-over-quarter.
  • 23 funds opened new Regenxbio positions in Q3 2025 and 15 closed out, a net change of +8 holders.
  • The largest Regenxbio buyer in Q3 2025 was Morgan Stanley, an estimated $6.27M added.
  • The largest Regenxbio seller in Q3 2025 was Balyasny Asset Management, an estimated $6.54M sold.

Based on aggregated 13F filings for Q3 2025.